LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES

F. Uhl, S. Vierkotten, G. Burgstaller, M. Lindner, O. Eickelberg, S. Meiners, M. Königshoff (Munich, Gauting, Germany)

Source: International Congress 2014 – Lung cell biology in injury and repair
Session: Lung cell biology in injury and repair
Session type: Thematic Poster Session
Number: 874
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Uhl, S. Vierkotten, G. Burgstaller, M. Lindner, O. Eickelberg, S. Meiners, M. Königshoff (Munich, Gauting, Germany). LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES. Eur Respir J 2014; 44: Suppl. 58, 874

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

THE HUMAN LUNG: DID EVOLUTION GET IT WRONG?
Source: Eur Respir J 2007; 29: 823
Year: 2007


ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019

Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020



DEFICIENT MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: ROLE OF SATELLITE CELLS
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019

LATE-BREAKING ABSTRACT: THE FATE OF INHALED DRUG: CORTICOSTEROID PARTICLE SIZE EFFECTS IN ASTHMA
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017


PULMONARY REHABILITATION AFTER LUNG TRANSPLANTATION: DEVELOPMENT OF A PROTOCOL
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Late Breaking Abstract - SMOKING PREVALENCE AND CHARACTERIZATION OF PATIENTS AT DIAGNOSIS OF DIFFUSE INTERSTITIAL LUNG DISEASES
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



NOVEL KLF4-FOXO1 INTERACTOME IN LUNG FIBROBLASTS:REGULATOR OF MYOFIBROBLASTS IN HYPEROXIA-INDUCED LUNG INJURY
Source: Virtual Congress 2020 – Airway development in health and disease
Year: 2020




FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


THE PROGRESSION OF IMMUNE DISORDERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH CHANGES IN LEUKOCYTE MEMBRANE FATTY ACID COMPOSITION
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020

HOME MONITORING WITH A PORTABLE OXYMETER AS AN ALTERNATIVE METHOD TO ASSESS OXYGEN SATURATION DURING DAILY ACTIVITIES IN INTERSTITIAL LUNG DISEASES (ILDs).
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


EARLY DIAGNOSIS OF LUNG VENTILATION EVENNESS DISORDERS USING NONINVASIVE IMAGING
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021